| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cancer Research Center, Boston University School of Medicine, Boston, Massachusetts 02118
We have investigated the mechanism of S-phase arrest elicited by the carcinogen benzo(a)pyrene dihydrodiol epoxide (BPDE) in p53-deficient cells. Inhibition of DNA synthesis after BPDE treatment was rapid and dose dependent (
50% inhibition after 2 h with 50 nM BPDE). Cells treated with low doses (50100 nM) of BPDE resumed DNA synthesis after a delay of
48 h, whereas cells that received high doses of BPDE (600 nM) failed to recover from S-phase arrest. The checkpoint kinase Chk1 (but not Chk2) was phosphorylated after treatment with low doses of BPDE. High concentrations of BPDE elicited phosphorylation of both Chk1 and Chk2. Adenovirus-mediated expression of "dominant-negative" Chk1 (but not dominant-negative Chk2) and the Chk1 inhibitor UCN-01 abrogated the S-phase delay elicited by low doses of BPDE. Consistent with a role for the caffeine-sensitive ATM or ATR protein kinase in low-dose BPDE-induced S-phase arrest, both Chk1 phosphorylation and S-phase arrest were abrogated by caffeine. However, low doses of BPDE elicited Chk1 phosphorylation and S-phase arrest in AT cells (from ataxia telangiectasia patients), demonstrating that ATM is dispensable for S-phase checkpoint responses to this genotoxin. BPDE-induced Chk1 phosphorylation and S-phase arrest were abrogated by caffeine treatment in AT cells, suggesting that a caffeine-sensitive kinase other than ATM is an important mediator of responses to BPDE-adducted DNA. Overall, our data demonstrate the existence of a caffeine-sensitive, Chk1-mediated, S-phase checkpoint that is operational in response to BPDE.
This article has been cited by other articles:
![]() |
P. Liu, J. Lu, W. V. Cardoso, and C. Vaziri The SPARC-related Factor SMOC-2 Promotes Growth Factor-induced Cyclin D1 Expression and DNA Synthesis via Integrin-linked Kinase Mol. Biol. Cell, January 1, 2008; 19(1): 248 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Heffernan, K. Unsal-Kacmaz, A. N. Heinloth, D. A. Simpson, R. S. Paules, A. Sancar, M. Cordeiro-Stone, and W. K. Kaufmann Cdc7-Dbf4 and the Human S Checkpoint Response to UVC J. Biol. Chem., March 30, 2007; 282(13): 9458 - 9468. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Caino, J. L. Oliva, H. Jiang, T. M. Penning, and M. G. Kazanietz Benzo[a]pyrene-7,8-dihydrodiol Promotes Checkpoint Activation and G2/M Arrest in Human Bronchoalveolar Carcinoma H358 Cells Mol. Pharmacol., March 1, 2007; 71(3): 744 - 750. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Liu, L. R. Barkley, T. Day, X. Bi, D. M. Slater, M. G. Alexandrow, H.-P. Nasheuer, and C. Vaziri The Chk1-mediated S-phase Checkpoint Targets Initiation Factor Cdc45 via a Cdc25A/Cdk2-independent Mechanism J. Biol. Chem., October 13, 2006; 281(41): 30631 - 30644. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Bi, L. R. Barkley, D. M. Slater, S. Tateishi, M. Yamaizumi, H. Ohmori, and C. Vaziri Rad18 Regulates DNA Polymerase {kappa} and Is Required for Recovery from S-Phase Checkpoint-Mediated Arrest. Mol. Cell. Biol., May 1, 2006; 26(9): 3527 - 3540. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Shiotani, M. Kobayashi, M. Watanabe, K.-i. Yamamoto, T. Sugimura, and K. Wakabayashi Involvement of the ATR- and ATM-Dependent Checkpoint Responses in Cell Cycle Arrest Evoked by Pierisin-1 Mol. Cancer Res., February 1, 2006; 4(2): 125 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Y. Xu, M. Loignon, F.-Y. Han, L. Panasci, and R. Aloyz Xrcc3 Induces Cisplatin Resistance by Stimulation of Rad51-Related Recombinational Repair, S-Phase Checkpoint Activation, and Reduced Apoptosis J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 495 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Bi, D. M. Slater, H. Ohmori, and C. Vaziri DNA Polymerase {kappa} Is Specifically Required for Recovery from the Benzo[a]pyrene-Dihydrodiol Epoxide (BPDE)-induced S-phase Checkpoint J. Biol. Chem., June 10, 2005; 280(23): 22343 - 22355. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Horton, D. F. Stefanick, J. M. Naron, P. S. Kedar, and S. H. Wilson Poly(ADP-ribose) Polymerase Activity Prevents Signaling Pathways for Cell Cycle Arrest after DNA Methylating Agent Exposure J. Biol. Chem., April 22, 2005; 280(16): 15773 - 15785. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-P. Lu, Y.-R. Lou, Q.-Y. Peng, J.-G. Xie, and A. H. Conney Stimulatory Effect of Topical Application of Caffeine on UVB-Induced Apoptosis in the Epidermis of p53 and Bax Knockout Mice Cancer Res., July 15, 2004; 64(14): 5020 - 5027. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Loegering, S. J. H. Arlander, J. Hackbarth, B. T. Vroman, P. Roos-Mattjus, K. M. Hopkins, H. B. Lieberman, L. M. Karnitz, and S. H. Kaufmann Rad9 Protects Cells from Topoisomerase Poison-induced Cell Death J. Biol. Chem., April 30, 2004; 279(18): 18641 - 18647. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. H. Arlander, A. K. Eapen, B. T. Vroman, R. J. McDonald, D. O. Toft, and L. M. Karnitz Hsp90 Inhibition Depletes Chk1 and Sensitizes Tumor Cells to Replication Stress J. Biol. Chem., December 26, 2003; 278(52): 52572 - 52577. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Parrilla-Castellar and L. M. Karnitz Cut5 Is Required for the Binding of Atr and DNA Polymerase {alpha} to Genotoxin-damaged Chromatin J. Biol. Chem., November 14, 2003; 278(46): 45507 - 45511. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Post, A. E. Tomkinson, and E. Y.-H. P. Lee The human checkpoint Rad protein Rad17 is chromatin-associated throughout the cell cycle, localizes to DNA replication sites, and interacts with DNA polymerase {epsilon} Nucleic Acids Res., October 1, 2003; 31(19): 5568 - 5575. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. S. Chini and J. Chen Human Claspin Is Required for Replication Checkpoint Control J. Biol. Chem., August 8, 2003; 278(32): 30057 - 30062. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Roos-Mattjus, K. M. Hopkins, A. J. Oestreich, B. T. Vroman, K. L. Johnson, S. Naylor, H. B. Lieberman, and L. M. Karnitz Phosphorylation of Human Rad9 Is Required for Genotoxin-activated Checkpoint Signaling J. Biol. Chem., June 27, 2003; 278(27): 24428 - 24437. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Furuta, H. Takemura, Z.-Y. Liao, G. J. Aune, C. Redon, O. A. Sedelnikova, D. R. Pilch, E. P. Rogakou, A. Celeste, H. T. Chen, et al. Phosphorylation of Histone H2AX and Activation of Mre11, Rad50, and Nbs1 in Response to Replication-dependent DNA Double-strand Breaks Induced by Mammalian DNA Topoisomerase I Cleavage Complexes J. Biol. Chem., May 23, 2003; 278(22): 20303 - 20312. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Weiss, P. Leder, and C. Vaziri Critical Role for Mouse Hus1 in an S-Phase DNA Damage Cell Cycle Checkpoint Mol. Cell. Biol., February 1, 2003; 23(3): 791 - 803. [Abstract] [Full Text] |
||||
![]() |
H. Miao, J. A. Seiler, and W. C. Burhans Regulation of Cellular and SV40 Virus Origins of Replication by Chk1-dependent Intrinsic and UVC Radiation-induced Checkpoints J. Biol. Chem., January 31, 2003; 278(6): 4295 - 4304. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |